Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Community
/
United States
/
Pharmaceuticals & Biotech
/
Phibro Animal Health
PAHC
Phibro Animal Health
Regulatory Pressures And Alternative Proteins Will Shrink Animal Health Market
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 4 Analysts
Published
13 Jul 25
Updated
16 Aug 25
0
Set Fair Value
0
votes
Share
AnalystLowTarget
's Fair Value
US$19.00
67.6% overvalued
intrinsic discount
16 Aug
US$31.85
Loading
1Y
76.3%
7D
7.3%
Author's Valuation
US$19.0
67.6% overvalued
intrinsic discount
AnalystLowTarget Fair Value
View Valuation
Narrative
Updates
0
Valuator
Company Info
Notes
AnalystLowTarget Fair Value
US$19.0
67.6% overvalued
intrinsic discount
Future estimation in
3 Years
time period
Past
Future
0
2b
2014
2017
2020
2023
2025
2026
2028
Revenue US$1.5b
Earnings US$94.4m
Revenue
Profit Margin
Future PE
Revenue
% p.a.
0
Decrease
Increase
Current revenue growth rate
8.40%
Pharma revenue growth rate
0.55%
Other Inputs & Calculation
Risk Level (Discount Rate)
Our default considers factors like the company's size, volatility, profitablity and country of operation.
Risk Level (Discount Rate)
%
0
Decrease
Increase
Current discount rate
6.78%
Calculation
US$94.38m
Earnings '28
x
9.80x
PE Ratio '28
=
US$925.20m
Market Cap '28
US$925.20m
Market Cap '28
/
40.62m
No. shares '28
=
US$22.77
Share Price '28
US$22.77
Share Price '28
Discounted to 2025 @ 6.78% p.a.
=
US$18.71
Fair Value '25
